Literature DB >> 32960425

Higher cardiovascular mortality in men with persistent dipstick hematuria.

Kunitoshi Iseki1, Tsuneo Konta2, Koichi Asahi2, Kunihiro Yamagata2, Shouichi Fujimoto2, Kazuhiko Tsuruya2, Ichiei Narita2, Masato Kasahara2, Yugo Shibagaki2, Toshiki Moriyama2, Masahide Kondo2, Tsuyoshi Watanabe2.   

Abstract

BACKGROUND: We previously reported that dipstick hematuria (UH) was associated with higher all-cause mortality in men, but not in women. We extended the observation and examined the causes of death using repeated urinalysis in men.
METHODS: Subjects were those who participated the Tokutei-Kenshin between 2008 to 2015 in seven districts. Using National database of death certificate, we identified those who might have died and confirmed further with the collaborations of the regional National Health Insurance agency and public health nurses. Dipstick results of 1 + and higher were defined as hematuria. Hazard ratio (HR) and 95% confidence interval (CI) were calculated using the Cox proportional hazard analysis. We adjusted for age, body mass index, eGFR, proteinuria, comorbid condition (diabetes mellitus, hypertension, and dyslipidemia), past history (stroke, heart disease, and kidney disease), and lifestyle (smoking, drinking, walking, and exercise).
RESULTS: A total of 170,119 men were studied and 70,350 (41.4% of the total) were re-examined next year. The prevalence of UH (-/-), UH (-/+), UH (±), and UH (+ /+) was 77.2% (N = 54,298), 14.0% (N = 9,838), 1.4% (N = 1014) and 7.4% (N = 5,200), respectively. We identified 1,162 deaths (1.7% of the total of the re-examined). The adjusted HR (95% CI) was 1.49 (1.22-1.81) for all-cause mortality and 1.83 (1.23-2.71) for cardiovascular death compared to those with UH (-/-), respectively. However, that for cancer mortality risk was not significant: 1.23 (0.92-1.64).
CONCLUSIONS: In men, persistent dipstick hematuria is a significantly risk factor of all-cause mortality, in particular cardiovascular death among general screening participants.

Entities:  

Keywords:  Cardiovascular disease; Hematuria; Screening; Survival

Mesh:

Year:  2020        PMID: 32960425     DOI: 10.1007/s10157-020-01971-z

Source DB:  PubMed          Journal:  Clin Exp Nephrol        ISSN: 1342-1751            Impact factor:   2.801


  2 in total

Review 1.  Atheroembolic renal disease.

Authors:  Kulwant S Modi; Venkateswara K Rao
Journal:  J Am Soc Nephrol       Date:  2001-08       Impact factor: 10.121

2.  A long-term follow-up study of asymptomatic hematuria and/or proteinuria in adults.

Authors:  K Yamagata; Y Yamagata; M Kobayashi; A Koyama
Journal:  Clin Nephrol       Date:  1996-05       Impact factor: 0.975

  2 in total
  4 in total

1.  Association of microscopic hematuria with long-term mortality in patients with hypertensive crisis.

Authors:  Mi-Yeon Yu; Jin-Kyu Park; Byung Sik Kim; Hyun-Jin Kim; Jinho Shin; Jeong-Hun Shin
Journal:  J Nephrol       Date:  2022-08-24       Impact factor: 4.393

2.  Hematuria, bone health, and cardiovascular mortality.

Authors:  Minako Wakasugi; Junichiro James Kazama
Journal:  Clin Exp Nephrol       Date:  2021-01-07       Impact factor: 2.801

3.  Association between 3-Year Repetitive Isolated Hematuria and eGFR Deterioration in an Apparently Healthy Population: A Retrospective Cohort Study.

Authors:  Mami Ishida; Keiichi Matsuzaki; Hitoshi Suzuki; Yusuke Suzuki; Takashi Kawamura; Yoshinori Marunaka; Taku Iwami
Journal:  Int J Environ Res Public Health       Date:  2022-09-12       Impact factor: 4.614

4.  Long-Term Cardiovascular Mortality among 80,042 Older Patients with Bladder Cancer.

Authors:  Tianwang Guan; Miao Su; Zehao Luo; Weien Peng; Ruoyun Zhou; Zhenxing Lu; Manting Feng; Weirun Li; Yintong Teng; Yanting Jiang; Caiwen Ou; Minsheng Chen
Journal:  Cancers (Basel)       Date:  2022-09-21       Impact factor: 6.575

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.